Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT00193245 · COMPLETED
Trial details
- NCT number
- NCT00193245
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
- Primary completion
- 2005-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.